Solid 1H24 earnings, better NEV outlook
Building Better Formal Tvet Systems
–Better-than-feared 3Q results
Better profits achieved across 3 business lines
1Q23 beat on better GPM; Maintain HOLD on fair valuation
–3Q23 earnings beat on better product mix and record-high GPM
拜登《Build Back Better》法案有望加速落地,美国电车市场或将爆发
Hopson: weaker but much better than peers FY22
Better-than-expected 3Q results drove enhanced full-year outlook
Harnessing the Benefits of Externally Controlled Clinical Trials (ECTs) to Accelerate Development of Better Medicines